Goal-oriented Intervention in Parkinson's Disease

December 13, 2016 updated by: Marie Carmen Valenza, Universidad de Granada

Effects of a Goal-oriented Upper-limb Intervention in Patients With Parkinson's Disease

Upper-limb disorders in patients with Parkinson's disease include decreased speed and amplitude of movements, difficulty in sequential tasks, and disrupted execution of fine manipulative hand activities.The aim of the study was to evaluate the effects of home-based goal-oriented upper limb intervention in patients with Parkinson's disease.

Study Overview

Detailed Description

Parkinson's disease is a neurodegenerative neurological disorders involving progressive impairment in motor, mood and cognitive functions. Movement disorders have a negative impact on individual's ability to perform well-learned motor skills. These include akinesia, bradykinesia, rigidity and tremor at rest.

A goal-planning process should be useful to ensure that patients agree on the goals of rehabilitation. Thus, the purpose of the study was to evaluate the effects of home-based goal-oriented upper limb intervention in patients with Parkinson's disease.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Granada, Spain, 18071
        • Department of Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of Parkinson's Disease.
  • Stage II-III of disease progression as defined by the Hoehn and Yahr scale.
  • Upper limbs impairment

Exclusion Criteria:

  • Clinical signs of dementia or psychiatric disturbance.
  • Comprehension deficits that prevented them from following verbal commands.
  • Visual or acoustic limitations.
  • A neurologic condition other than Parkinson's Disease.
  • Musculoskeletal disorders and/or if they had previous trauma or fracture of upper extremity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Patients in the experimental group received a Goal-oriented upper limb intervention.
The Goal-oriented upper-limb intervention evaluated patients' expectations and the environmental factors influencing the performance of the specific task were identified for each of the three tasks. Patients were asked to perform the activity at home. After this, the observable target behavior corresponding to the target activity was determined. Then, an occupational and a physical therapist worked together with the patient to identify the assistance required to perform this activity such as human assistance, technical aids, assistive devices or verbal guidance.
Active Comparator: Control group
Patients in the control group received a standard upper limb intervention
The standard upper limb intervention involved active upper limb range of motion, manual dexterity involving grasp and manipulation of small pieces such as marbles and stretching upper limb exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goals attainment
Time Frame: Change from baseline goals attainment assessment at 4 weeks.
Attainment of goals was assessed using the Goal Attainment Scaling, a method for quantifying progress on the achievement of specific goals
Change from baseline goals attainment assessment at 4 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Manual dexterity
Time Frame: Change from baseline manual dexterity at 4 weeks
Manual dexterity was assessed using Purdue Pegboard test (one task with the dominant hand, one with the non-dominant hand, one with both hands and assembly task).
Change from baseline manual dexterity at 4 weeks
Handgrip strength
Time Frame: Change from baseline handgrip strength at 4 weeks
Handgrip strength was assessed using a dynamometer
Change from baseline handgrip strength at 4 weeks
Finger prehension force
Time Frame: Change from baseline finger prehension force at 4 weeks
Finger prehension force was assessed using a pinch meter
Change from baseline finger prehension force at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2016

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

October 17, 2016

First Submitted That Met QC Criteria

October 17, 2016

First Posted (Estimate)

October 19, 2016

Study Record Updates

Last Update Posted (Estimate)

December 14, 2016

Last Update Submitted That Met QC Criteria

December 13, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe